期刊文献+

慢性乙型肝炎患者血清中miR-122、miR-375表达分析 被引量:2

原文传递
导出
摘要 目的探索慢性乙型肝炎患者血清中miR-122、miR-375表达情况。方法选取2012—2013年郑州大学第二附属医院,经检测诊断为慢性乙肝病人488例,同时选取健康体检者488例作为对照。采外周血2ml,提取RNA,定量逆转录PCR方法检测miR-122和miR-375相对表达水平。与ELISA五项、HBV DNA和ALT检测结果对比分析。结果健康对照组和慢性乙肝组血清中miR-122和miR-375相对表达量分别为(1.92±0.67)、(10.38±2.27)和(1.24±0.36)、(6.57±1.26)。在慢性乙肝病人中,HBeAg阳性病人的miR-122和miR-375相对表达量最高(13.22±2.34)和(8.11±1.34),与HBeAg阴性的非活动性携带者比较,差异均有显著性(P<0.05)。结论慢性乙肝患者血清中miR-122和miR-375相对表达量显著升高;不同慢性乙肝病人中miR-122和miR-375表达水平升高存在差异,其中HBeAg阳性病人的升高最显著,而非活动性携带者的升高最少。
出处 《医药论坛杂志》 2014年第3期94-96,共3页 Journal of Medical Forum
  • 相关文献

参考文献9

  • 1Dienstag JL. Hepatitis B virus infection [ J ]. N Eng J Med, 2008,359 (14) : 1486-1500.
  • 2Zhang Y,Jia Y,Zheng R,et al. Plasma microRNA - 122 as a bi- omarker for viral alcohol and chemical related hepatic diseases [J]. Clin Chem,2010,56(3):1830-1838.
  • 3Li - Min Li, Zhi - Bin Hu, Zhen - Xian Zhou, et al. Serum mi- croRNA Profiles Serve as Novel Biomarkers for HBV Infection and Diagnosis of HBV - Positive Hepatocarcinonm [ J ]. Cancer Res,2010,70(23) :9797-9807.
  • 4Ambros, V. The functions of animal microRNAs [ J ]. Nature,2004,431 (7006) :350-355.
  • 5Griffiths - Jones S, Saini HK, Van Dongen, et al. miRBase : tools for mieroRNA genomies [ J ]. Nucleic Acids Res, 2008,36: D154-D158.
  • 6Skalsky RL, Cullcn BR. Viruses, mieroRNAs,and host interac- tions [ J ]. Annu Rev Mierobiol,2010,64 : 123-141.
  • 7Novellino L, Rossi RL, Bonino F, et al. Circulating hepatitis B surface antigen particles carry hepatocellular mieroRNAs [ J ]. PLoS One,2012,7 ( 3 ) : e31952.
  • 8Hayes CN,Akamatsu S,Tsuge M,et al. Hepatitis B virus specif- ic nfiRNAs and Argonante2 play a role in the viral life cycle [ J]. PLoS One,2012,7 (10) : e47490.
  • 9Gao P, Wong CC, Tung EK, et al. Deregulation of mieroRNA ex- pression occurs early and accumulates in early stages of HBV - associated multistep hepatoear - einogenesis [ J ]. J Hepatol, 2011,54(6) :1177-1184.

同被引文献38

  • 1侯晋,曹雪涛.MicroRNA与肝癌诊治:新的机遇和挑战[J].中国肿瘤生物治疗杂志,2015,22(1):1-7. 被引量:10
  • 2Jemal A, Bray F, Center M M, et al. Global cancer statistics [J]. CA Cancer J Clin, 2011, 61(2): 69-90.
  • 3Ayub A, Ashfaq U A, Haque A. HBV induced HCC: major risk factors from genetic to molecular level [J]. Biomed Res Int, 2013, 2013: 810461.
  • 4Johnson P J. How do mechanisms of hepatocarcinogenesis (HBV, HCV, and NASH) affect our understanding and approach to HCC[J]. Am Soc Clin Oncol Educ Book, 2013, 33:e132.
  • 5Zhu H T, Dong Q Z, Sheng Y Y, et al. MicroRNA-29a-5p is a novel predictor for early recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection[J]. PLoS One, 2012, 7(12): e52393.
  • 6Croce C M. Causes and consequences ofmicroRNA dysregulation in cancer[J]. Nat Rev Genet, 2009, 10(10): 704-714.
  • 7Fabian M R, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by mieroRNAs[J]. Annu Rev Bioehem, 2010, 79:351-379.
  • 8Zahran F, Ghalwash D, Shaker O, et al. Salivary Micro-RNAs in Oral Cancer[J]. Oral Dis, 2015, 21(6): 739-747.
  • 9Kang L, Man J, Tan Y, et al. MiR-34a Suppresses the Breast Cancer Stem Cell-like Charactedstics by Downregulating Notchl Pathway[J]. Cancer Sci, 2015, 106(6): 700-708.
  • 10Patnaik S, MaUiek IL Kannisto E, et al. MiR-205 and MiR-375 MicroRNA Assays to Distinguish Squamous Cell Carcinoma from Adenocarcinoma in Lung Cancer Biopsies [J]. J Thorac Oncol, 2015, 10(3): 446-453.

引证文献2

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部